Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.339, 2001-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Galantamine worth it for AD in many countries
Inpharma, Vol. 1, Iss. 1455, 2004-01 ,pp. :
Access to resources
Recommend
Galantamine beneficial in mild-to-moderate AD
Inpharma, Vol. 1, Iss. 1250, 2000-01 ,pp. :
Galantamine potentially cost saving for AD in Sweden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 376, 2002-01 ,pp. :
Galantamine potentially cost saving for AD in Sweden
Inpharma, Vol. 1, Iss. 1351, 2002-01 ,pp. :
Galantamine is of potential benefit in the treatment of schizophrenia
Inpharma, Vol. 1, Iss. 1354, 2002-01 ,pp. :